Emergent BioSolutions
EBS
#6766
Rank
โ‚ฌ0.54 B
Marketcap
10,22ย โ‚ฌ
Share price
-1.24%
Change (1 day)
18.25%
Change (1 year)

Emergent BioSolutions (EBS) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ1.25 Billion

According to Emergent BioSolutions 's latest financial reports the company's total assets are โ‚ฌ1.25 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Emergent BioSolutions - Total assets on balance sheet (from 2004 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ1.33 B-19.03%
2023-12-31โ‚ฌ1.64 B-44.13%
2022-12-31โ‚ฌ2.95 B13.02%
2021-12-31โ‚ฌ2.61 B11.41%
2020-12-31โ‚ฌ2.34 B12.83%
2019-12-31โ‚ฌ2.07 B6.61%
2018-12-31โ‚ฌ1.94 B118.49%
2017-12-31โ‚ฌ0.89 B-3.29%
2016-12-31โ‚ฌ0.92 B-2.8%
2015-12-31โ‚ฌ0.94 B22.94%
2014-12-31โ‚ฌ0.77 B70.1%
2013-12-31โ‚ฌ0.45 B6.38%
2012-12-31โ‚ฌ0.42 B1.29%
2011-12-31โ‚ฌ0.42 B11.95%
2010-12-31โ‚ฌ0.37 B56.35%
2009-12-31โ‚ฌ0.24 B15.66%
2008-12-31โ‚ฌ0.20 B11.04%
2007-12-31โ‚ฌ0.18 B3.74%
2006-12-31โ‚ฌ0.18 B113.19%
2005-12-31โ‚ฌ84.69 M66.37%
2004-12-31โ‚ฌ50.9 M
2002-12-31โ‚ฌ21.8 M-24.27%
2001-12-31โ‚ฌ28.78 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Merck
MRK
โ‚ฌ111.26 B 8,766.94%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚ฌ0.19 B-84.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ70.82 B 5,544.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚ฌ0.55 B-55.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ179.27 B 14,186.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ34.23 B 2,627.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
โ‚ฌ9.7 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA